Report Summary
Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials are expected to be biocompatible and not cause inflammation or rejection. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial fluid substitutes. Among the prominent applications for orthopedic biomaterials are surface coatings for hip prostheses, bone cements, bone defect fillers, and fracture fixation plates.
This report focuses on orthopedic biomaterials. The specific areas covered in this report are the products and markets for bone allografts and bone graft substitutes, which include allograft bone substitutes, ceramic-based, polymer-based, factor-based (recombinant growth factors) and hyaluronic acid synovial fluid substitutes.
Kalorama's Orthopedic Biomaterials, World Market, one of the few resources available on this market, includes the following segments:
- Allograft Products (including DBM, Machined Bone and Standard Allograft)
- Ceramic Products
- Polymer Products
- rhBMP Products
- HA Viscosupplemental Products
As part of Kalorama Information's exhaustive coverage of the orthopedic biomaterials market for each area, the following data are provided:
- Historical Revenues from 2001-2005
- Forecasts to 2012
- Competitive Market Share
- Discussion of Issues and Trends
- Review of New Products
- Company Profiles
A truly global resource, this report provides information on the following world regions:
- US
- Europe
- Asia
- Rest of World
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, orthopedic surgeons, research institutes, and government personnel. These sources were the primary basis for information specifically relating to trends in the orthopedic biomaterials industry, revenue and market share data presented in this report. Specific interviews with orthopedic implant device and biomaterial company representatives included marketing directors, division managers, and product representatives.